Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 58

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 58
---
 Special Meeting. If you have questions regarding the certification of your position or delivery of your stock, please contact:

<div align='center'>Continental Stock Transfer & Trust Company 
 1 State Street, 30th Floor 
 New York, New York 10004 
 Attn: Mark Zimkind 
 E-mail: mzimkind@continentalstock.com

xxiii</div>

TABLE OF CONTENTS

#### SUMMARY OF THE PROXY STATEMENT/PROSPECTUS
This summary highlights selected information from this proxy statement/prospectus and does not contain all of the information that may be important to you. To better understand the proposals to be considered at the Special Meeting, including the Business Combination Proposal, whether or not you plan to attend the Special Meeting, we urge you to read this entire proxy statement/prospectus (including the annexes) carefully, including the section entitled “Risk Factors” beginning on page 26. See also the section entitled “Where You Can Find More Information.”

Unless otherwise specified, all share amounts and share calculations: (i) assume no exercise of redemption rights by our public stockholders, (ii) assume that an aggregate of 17.5 million shares of ParentCo Common Stock will be issued to the Liminatus Members as consideration in the Business Combination, and (iii) do not include: (A) any warrants to purchase ParentCo Common Stock that will be outstanding following the Business Combination, or (B) any equity awards that may be issued under the proposed Incentive Plan following the Business Combination.

### Parties to the Business Combination

### IRIS ACQUISITION CORP
Iris is a blank check company, incorporated in Delaware, formed in November 2020 for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination. Based on its business activities, Iris is a “shell company” as defined under the Exchange Act because it has no operations and nominal assets consisting almost entirely of cash.

Iris’s Class A Common Stock is currently trading on the OTC Pink Marketplace under the symbol “IRAA”. Iris’s Redeemable Warrants are currently trading on the OTC Pink Marketplace under the symbol “IRAAW”. Additionally, shares of Iris’s Class A Common Stock and Iris’s Redeemable Warrants trade as Units consisting of one share of Class A Common Stock and one-fourth of one Redeemable Warrant, and are trading on the OTC Pink Marketplace under the symbol “IRAAU